List view / Grid view

Ursula Hirschkorn (European Pharmaceutical Review)

 

article

Big potential for small molecule drugs in cancer treatment

20 June 2024 | By ,

With recent recommendation of Takeda’s fruquintinib by the European Medicines Agency (EMA), EPR spoke to Dr Sebastian Stintzing, Professor of Medicine, Head of the Department of Hematology, Oncology, and Tumor Immunology (CCM) of The Charité University Hospital in Berlin and investigator on the FRESCO-2 trial, to find out more about…